Drug prior‑auth goes digital

CMS has proposed extending its prior‑authorization interoperability rules to prescription drugs, meaning drug authorizations would now be subject to the same digital timeliness and disclosure standards already applied elsewhere. That shift would force payers and providers to expose drug‑authorization status and metrics through APIs and public reporting, not just internal queues. The proposal was reported by Modern Healthcare and picked up in broader coverage of the prior‑authorization reform wave. (modernhealthcare.com) (beckerspayer.com)